Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024
The NACHT, leucine-rich repeat, and pyrin domain–containing protein 3 (NLRP3) inflammasome plays an essential role in myocardial infarction (MI) development. Up to now, no bibliometric analyses of NLRP3 in MI have been performed. Publications related to NLRP3 in MI from 1 January 2013 to 20 August 2...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/cdr/5178894 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850077837372948480 |
|---|---|
| author | Jin-wen Wu Qi Lan Ding-shan Zhang Yu-hong Jian Lin Yu Rui Hao Ping Liu Gang Luo Ming-tai Chen Meng-nan Liu |
| author_facet | Jin-wen Wu Qi Lan Ding-shan Zhang Yu-hong Jian Lin Yu Rui Hao Ping Liu Gang Luo Ming-tai Chen Meng-nan Liu |
| author_sort | Jin-wen Wu |
| collection | DOAJ |
| description | The NACHT, leucine-rich repeat, and pyrin domain–containing protein 3 (NLRP3) inflammasome plays an essential role in myocardial infarction (MI) development. Up to now, no bibliometric analyses of NLRP3 in MI have been performed. Publications related to NLRP3 in MI from 1 January 2013 to 20 August 2024 were extracted from the Web of Science Core Collection (WoSCC). HistCite Pro, CiteSpace, VOSviewer, Scimago Graphica, and bibliometric online analysis program were used for bibliometric analysis and visualization. The impact of publications was assessed using the total global citation score (TGCS). A total of 324 articles (284 articles and 40 reviews) were included. China has published the most in this field, followed by the United States. Harbin Medical University was the leading institution for research related to NLRP3 in MI. Professor Abbate A. from the United States has made significant achievements in this field. International Immunopharmacology was the most active journal and Journal of Cardiovascular Pharmacology was the most cited journal. This study systematically summarizes the research results of NLRP3 in MI over the past 12 years. NLRP3 in myocardial ischemia–reperfusion injury (MIRI) will become a hot research topic, and translational research on NLRP3 inhibitors in MIRI will benefit a greater number of patients. |
| format | Article |
| id | doaj-art-71d67d2125dc49fab3b44fd72839e447 |
| institution | DOAJ |
| issn | 1755-5922 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiovascular Therapeutics |
| spelling | doaj-art-71d67d2125dc49fab3b44fd72839e4472025-08-20T02:45:42ZengWileyCardiovascular Therapeutics1755-59222025-01-01202510.1155/cdr/5178894Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024Jin-wen Wu0Qi Lan1Ding-shan Zhang2Yu-hong Jian3Lin Yu4Rui Hao5Ping Liu6Gang Luo7Ming-tai Chen8Meng-nan Liu9Department of Cardiovascular MedicineDepartment of Cardiovascular MedicineDepartment of Cardiovascular MedicineDepartment of Cardiovascular MedicineDepartment of OrthopaedicsSchool of NursingDepartment of Cardiovascular MedicineDepartment of Cardiovascular MedicineDepartment of Cardiovascular DiseaseDepartment of Cardiovascular MedicineThe NACHT, leucine-rich repeat, and pyrin domain–containing protein 3 (NLRP3) inflammasome plays an essential role in myocardial infarction (MI) development. Up to now, no bibliometric analyses of NLRP3 in MI have been performed. Publications related to NLRP3 in MI from 1 January 2013 to 20 August 2024 were extracted from the Web of Science Core Collection (WoSCC). HistCite Pro, CiteSpace, VOSviewer, Scimago Graphica, and bibliometric online analysis program were used for bibliometric analysis and visualization. The impact of publications was assessed using the total global citation score (TGCS). A total of 324 articles (284 articles and 40 reviews) were included. China has published the most in this field, followed by the United States. Harbin Medical University was the leading institution for research related to NLRP3 in MI. Professor Abbate A. from the United States has made significant achievements in this field. International Immunopharmacology was the most active journal and Journal of Cardiovascular Pharmacology was the most cited journal. This study systematically summarizes the research results of NLRP3 in MI over the past 12 years. NLRP3 in myocardial ischemia–reperfusion injury (MIRI) will become a hot research topic, and translational research on NLRP3 inhibitors in MIRI will benefit a greater number of patients.http://dx.doi.org/10.1155/cdr/5178894 |
| spellingShingle | Jin-wen Wu Qi Lan Ding-shan Zhang Yu-hong Jian Lin Yu Rui Hao Ping Liu Gang Luo Ming-tai Chen Meng-nan Liu Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024 Cardiovascular Therapeutics |
| title | Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024 |
| title_full | Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024 |
| title_fullStr | Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024 |
| title_full_unstemmed | Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024 |
| title_short | Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024 |
| title_sort | frontiers and hotspot evolution of nlrp3 inflammasome in myocardial infarction research a bibliometric analysis from 2013 to 2024 |
| url | http://dx.doi.org/10.1155/cdr/5178894 |
| work_keys_str_mv | AT jinwenwu frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT qilan frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT dingshanzhang frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT yuhongjian frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT linyu frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT ruihao frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT pingliu frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT gangluo frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT mingtaichen frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 AT mengnanliu frontiersandhotspotevolutionofnlrp3inflammasomeinmyocardialinfarctionresearchabibliometricanalysisfrom2013to2024 |